Department of Biomedical Engineering, University of Houston, Houston, Texas, USA.
Department of Neurosurgery, University of Colorado, Aurora, Colorado, USA.
Mov Disord. 2020 Jan;35(1):91-100. doi: 10.1002/mds.27800. Epub 2019 Jul 26.
Cross-frequency coupling has been reported in the STN of patients with PD, but its significance and functional role are still not well understood. This study investigates pharmacological modulations of subthalamic oscillations and their nonlinear cross-frequency interactions across three consecutive cycles over unique 24-hour-long recordings.
Identifying neurobiomarkers for PD can drive the development of novel personalized treatments by providing objective assessment of impairment. In particular, distinct frequency bands in LFP recordings and their interaction with one another have been shown to modulate with dopaminergic medication and thus, proposed as such biomarkers.
We recorded local field potentials 3 weeks postoperatively from externalized leads in 9 patients and correlated the neural patterns with improvements in motor signs over three medication intake cycles. We used two modalities to assess symptoms in the unmedicated OFF and the l-dopa-induced motor ON state: a subsection of the UPDRS and a keyboard tapping score measuring bradykinesia.
In the OFF state, the amplitude of high-frequency oscillations in the 200- to 300-Hz range was coupled with the phase of low-beta (13-22 Hz) in all patients. After transition to the ON state, three distinct coupling patterns were observed among subjects. Among these, patients showing ON coupling between high-beta (22-30 Hz) and high-frequency oscillations in the 300- to 400-Hz range had significantly greater improvement in bradykinesia, according to the keyboard scores.
Observing diminished coupling in the ON state, previous studies have hypothesized that the sole existence of coupling in STN has an "impeding" effect on normal processes, and thus it was considered to be pathological. In contrast, our observation of ON state coupling at distinct frequencies associated with the improvements in motor features suggest that the underlying mechanism of coupling might have impeding or enhancing effects depending on the coupled frequencies. © 2019 International Parkinson and Movement Disorder Society.
已有研究报道帕金森病(PD)患者的 STN 中存在跨频耦合现象,但对其意义和功能作用仍知之甚少。本研究通过对独特的 24 小时长记录中三个连续周期内 STN 振荡及其非线性跨频相互作用的药物调制进行研究。
PD 的神经生物标志物的识别可以通过对损伤进行客观评估来推动新型个性化治疗的发展。特别地,LFP 记录中的不同频带及其相互作用已被证明可以随着多巴胺能药物的变化而变化,因此被提出作为此类生物标志物。
我们在 9 名患者术后 3 周,通过外部导联记录局部场电位,并将神经模式与三个药物摄入周期内运动症状的改善相关联。我们使用两种方式评估未服药的 OFF 状态和 l-多巴诱导的运动 ON 状态下的症状:UPDRS 的一个小节和用于测量运动迟缓的键盘敲击评分。
在 OFF 状态下,所有患者的高频(200-300 Hz)振荡幅度与低频β(13-22 Hz)相位耦合。在过渡到 ON 状态后,观察到受试者之间存在三种不同的耦合模式。其中,根据键盘评分,在高β(22-30 Hz)和高频(300-400 Hz)振荡之间显示 ON 耦合的患者在运动迟缓方面有显著更大的改善。
先前的研究观察到 ON 状态下的耦合减少,假设 STN 中仅存在耦合对正常过程有“阻碍”作用,因此认为其是病理性的。相比之下,我们观察到 ON 状态下与运动特征改善相关的不同频率的耦合,表明耦合的潜在机制可能取决于耦合频率,具有阻碍或增强作用。 © 2019 国际帕金森病和运动障碍学会。